Eisai Announces Exclusive In-License of All U.S. Promotional Rights for Fragmin(R), an Injectable Anti-Clotting Agent

Source :: Internet Wire. September 28, 2005
Publication Year :: 2005
Abstract: TEANECK, NJ, Sep 28, 2005 (MARKET WIRE via COMTEX) -- Eisai Inc. (Headquarters: Teaneck, Chairman and CEO: Hajime Shimizu), a U.S. pharmaceutical subsidiary of Eisai Co., Ltd. (Headquarters: Tokyo, President […]

Subjects :: Pfizer Inc.
Eisai Company Ltd.
Fragmin (Medication)
Pharmaceutical industry

Tools